Search
                    Iowa Paid Clinical Trials
A listing of 815  clinical trials  in Iowa  actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
            529 - 540 of 815
        
                Iowa is currently home to 815 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including Iowa City, Des Moines, Sioux City and West Des Moines. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
            
                                                Featured Trial
                
                Healthy Participants Needed (Colonoscopy + Cancer Screening)
            
        Recruiting
            
        Earn $325 - $475 in electronic payment card compensation for your time and effort by participating in a clinical study to develop a blood test that may one day help screen for colon cancer. Take a quick quiz to see if you qualify.
    
    
                            Conditions: 
                                    
        
            
                        Healthy
                    
                                    
                        Healthy Volunteers
                    
                                    
                        Healthy Subjects
                    
                                    
                        Healthy Volunteer
                    
                                    
                        Healthy Participants
                    
                                    Featured Offer
                
                Lose Weight with GLP-1 Medications
            
        Recruiting
            
        Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®. 
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
    GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $50 off your first program with code policy-lab-50.
                            Conditions: 
                                    
        
            
                        Overweight
                    
                                    
                        Overweight and Obesity
                    
                                    
                        Obesity
                    
                                    
                        Weight Loss
                    
                                    
                        Morbid Obesity
                    
                                    Featured Trial
                
                Stroke Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Stroke
    
    
                            Conditions: 
                                    
        
            
                        Stroke
                    
                                    Featured Trial
                
                Chronic Kidney Disease (CKD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Chronic Kidney Disease (CKD)
    
    
                            Conditions: 
                                    
        
            
                        Chronic Kidney Disease (CKD)
                    
                                    Featured Trial
                
                Ischemic heart disease (IHD) Clinical Study
            
        Recruiting
            
        A clinical study for people that suffer with Ischemic heart disease (IHD)
    
    
                            Conditions: 
                                    
        
            
                        Ischemic heart disease (IHD)
                    
                                    
                
                                    A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to compare the efficacy of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple myeloma patients.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/26/2025
            
            Locations: University of Iowa, Iowa City, Iowa         
        
        
            Conditions: Multiple Myeloma
        
            
        
    
                
                                    Vitalis Cardio Pilot
                                
            
            
        Recruiting
                            
            
                The objective of this study was to evaluate the efficacy and feasibility of a 12-week behavioral counseling intervention that has been integrated into the primary care setting on psychosocial, behavioral, and health outcomes in a large sample of adults with at least one CVD risk factor.
Aim 1: Evaluate the efficacy of a 12-week behavioral counseling intervention on psychosocial outcomes of adults with at least one CVD risk factor.
H1: We hypothesize participants will improve their behavioral r...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 80 years
            Trial Updated:
                05/23/2025
            
            Locations: University of Iowa, Iowa City, Iowa         
        
        
            Conditions: Cardiovascular Disease Risk Factor
        
            
        
    
                
                                    Preop Laxatives in Robotic Urologic Surgery
                                
            
            
        Recruiting
                            
            
                Minimally-invasive surgery, either laparoscopic or robotic, is commonly used in urology. Several urologic procedures including prostatectomy, radical nephrectomy, and partial nephrectomy are now commonly performed robotically. Patients undergoing these procedures often have delayed return of bowel function and persistent gastrointestinal symptoms including nausea/vomiting, abdominal distension, and bloating for several days to weeks after surgery. Postoperative stool softeners and laxatives are...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 30 years and 100 years
            Trial Updated:
                05/23/2025
            
            Locations: University of Iowa Hospitals & Clinics, Iowa City, Iowa         
        
        
            
        
    
                
                                    Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)
                                
            
            
        Recruiting
                            
            
                Prospective, multicenter, unblinded study to evaluate outcomes of the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for patients in need of metatarsus adductus and hallux valgus correction.
Up to 80 subjects will be treated in this study at up to 13 clinical sites. Patients 14 years of age or older with symptomatic metatarsus adductus and hallux valgus will be eligible to participate based on the inclusion and exclusion criteria defined in the study protocol.             
        
        
    Gender:
                ALL
            Ages:
                Between 14 years and 65 years
            Trial Updated:
                05/22/2025
            
            Locations: Foot and Ankle Center of Iowa, Ankeny, Iowa         
        
        
            Conditions: Metatarsus Adductus, Hallux Valgus
        
            
        
    
                
                                    SPIROMICS Study of Early COPD Progression (SOURCE)
                                
            
            
        Recruiting
                            
            
                This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals.
The study has three main goals:
* To use CT scan imaging to identify which smokers will develop COPD.
* To identify biomarkers predictive of smokers that will develop COPD.
* To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD.
Procedures (methods): All participants will undergo study rela...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 30 years and 55 years
            Trial Updated:
                05/22/2025
            
            Locations: University of Iowa, Iowa City, Iowa         
        
        
            Conditions: COPD, Early-Onset
        
            
        
    
                
                                    Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
                                
            
            
        Recruiting
                            
            
                This is an open-label phase 2/3 study for individuals with Congenital Myotonic Dystrophy (Congenital DM1) who participated in the preceding AMO-02-MD-2-003 study or individuals with either Congenital or Childhood Onset DM1 who are treatment naïve.             
        
        
    Gender:
                ALL
            Ages:
                Between 6 years and 45 years
            Trial Updated:
                05/22/2025
            
            Locations: University of Iowa Hospitals and Clinics, Iowa City, Iowa         
        
        
            Conditions: Congenital Myotonic Dystrophy
        
            
        
    
                
                                    Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to learn about the interactions of markers of type 2 diabetes (T2DM) and periodontitis (PD). Study VPE00001 is a multi-center cross-sectional study. Participants will be categorized based on point-of-care hemoglobin A1c (HbA1c) and periodontal disease (PD) staging into 9 subgroups. The key objectives of the study are:
* To evaluate immune signatures in well-characterized populations with or without PD and/or T2DM
* To evaluate baseline clinical biomarkers of T2DM an...  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 30 years and 70 years
            Trial Updated:
                05/20/2025
            
            Locations: University of Iowa - Site Number : 8400002, Iowa City, Iowa         
        
        
            Conditions: Periodontal Disease
        
            
        
    
                
                                    Barriers and Facilitators to OTC Hearing Aids Success
                                
            
            
        Recruiting
                            
            
                Hearing aids can improve hearing, communication, and overall quality of life for people with hearing loss. However, not many people use hearing aids. A common reason is that hearing aids are expensive and hard to get. The traditional way to get hearing aids involves multiple visits to licensed audiologists for identifying hearing loss, customizing the aids, and ongoing maintenance. This traditional method is called the AUD pathway.
Over-the-counter (OTC) hearing aids offer a different approach....  Read More             
        
        
    Gender:
                ALL
            Ages:
                Between 18 years and 89 years
            Trial Updated:
                05/20/2025
            
            Locations: University of Iowa, Iowa City, Iowa         
        
        
            Conditions: Hearing Loss, Sensorineural, Presbycusis
        
            
        
    
                
                                    Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
                                
            
            
        Recruiting
                            
            
                The purpose of this study is to find out what effects an immunotherapy drug, called pembrolizumab, combined with a radioactive drug, called lutetium Lu 177 dotatate (Lutathera®) have on patients with Merkel cell carcinoma. Pembrolizumab works by helping patient's immune system to fight cancer. Lutathera works by killing cancer cells. Pembrolizumab is approved by the FDA to treat Merkel cell cancer and has caused some Merkel cell cancers to shrink and/or resolve. Lutathera is FDA-approved to trea...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/20/2025
            
            Locations: University of Iowa Hospitals and Clinics, Iowa City, Iowa         
        
        
            Conditions: Merkel Cell Carcinoma
        
            
        
    
                
                                    Single Arm Study of Neoadjuvant Dostarlimab in Stage II and III Deficient Mismatch Repair Colon Cancers
                                
            
            
        Recruiting
                            
            
                This is a Phase II, single arm study looking at the rate of major clinical response and non-operative management in Stage II and III colon cancer after 18 weeks (up to 6 cycles) of neoadjuvant dostarlimab.             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/20/2025
            
            Locations: University of Iowa Hospitals & Clinics, Iowa City, Iowa         
        
        
            Conditions: Colon Cancer, DMMR Colorectal Cancer
        
            
        
    
                
                                    S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
                                
            
            
        Recruiting
                            
            
                This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving...  Read More             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/20/2025
            
            Locations: McFarland Clinic - Ames, Ames, Iowa         
        
        
            Conditions: Extensive Stage Lung Small Cell Carcinoma, Limited Stage Lung Small Cell Carcinoma, Lung Small Cell Carcinoma
        
            
        
    
                
                                    Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
                                
            
            
        Recruiting
                            
            
                To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in patients with degenerative mitral regurgitation (DMR) who have been determined to be at prohibitive risk for mitral valve surgery by the Heart Team, and in patients with functional mitral regurgitation (FMR) on guideline directed medical therapy (GDMT)             
        
        
    Gender:
                ALL
            Ages:
                18 years and above
            Trial Updated:
                05/19/2025
            
            Locations: University of Iowa Hospitals & Clinics, Iowa City, Iowa         
        
        
            Conditions: Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
        
            
        
    